[The safety of the derivatives of retinoic acid administered topically during pregnancy].
Sabaté
M
M
Institut Català de Farmacologia, Servei de Farmacologia Clínica, Hospital Vall d'Hebron, Barcelona.
Aguilera
C
C
D000152:Acne Vulgaris / Q000188:drug therapy*; D000287:Administration, Topical; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D014212:Tretinoin / Q000009:adverse effects*
D007641:Keratolytic Agents; D014212:Tretinoin
Seguridad de los derivados del ácido retinoico administrados por vía tópica durante el embarazo.